Verition Fund Management’s ACELYRIN SLRN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLRN
TCM
ACMC
MAP
O
VP
VCIM
TCM
Verition Fund Management's SLRN Position: Q1 2025 in Review
Verition Fund Management sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 27,480 shares — an estimated $86.3K sold.
Verition Fund Management first reported a position in SLRN in Q1 2024 and held it in 4 quarters. The position peaked at $543K in Q3 2024. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.
- Verition Fund Management reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
- Verition Fund Management sold 27,480 ACELYRIN shares in Q1 2025, an estimated $86.3K.
- Verition Fund Management first reported a position in ACELYRIN in Q1 2024 and held it in 4 quarters.
- Verition Fund Management's ACELYRIN position peaked at $543K in Q3 2024.
- 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.
Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.